Evidence map›Paper›PMID 28514677›Full record

ArticleImmunity2017

Human Group 1 Innate Lymphocytes Are Negative for Surface CD3ε but Express CD5.

Florence Roan, Steven F Ziegler

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in Immunity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Phenotypic analysis of the pediatric immune response to SARS-CoV-2 by flow cytometry.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2022
    Article
  4. Review
  5. Article
  6. Innate Lymphoid Cells at the Maternal-Fetal Interface in Human Pregnancy.International journal of biological sciences · 2020
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Human CD5Frontiers in immunology · 2017
    Article
  12. Epigenomic Views of Innate Lymphoid Cells.Frontiers in immunology · 2017
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Florence RoanImmunology Program, Benaroya Research Institute, Seattle, Washington 98101, USA.
Steven F ZieglerImmunology Program, Benaroya Research Institute, Seattle, Washington 98101, USA; Department of Immunology, University of Washington School of Medicine, Seattle, Washington 98195, USA. Electronic address: sziegler@benaroyaresearch.org.
Benaroya Research InstituteUniversity of Washington · US

Funding

TSLP and the Pathophysiology of AsthmaR01AI068731 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI ZIEGLER, STEVEN F · 2006 to 2016
$4.5M
IL-33 and food allergyR01AI124220 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI ZIEGLER, STEVEN F · 2016 to 2020
$3.0M
Control of tumor growth and metastasis by the cytokine TSLPR01CA182783 · NCI · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI ZIEGLER, STEVEN F · 2014 to 2018
$2.1M
NCI NIH HHS R01 CA182783NIAID NIH HHS R01 AI068731NIAID NIH HHS R01 AI124220
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CD5 AntigensLymphocytesHumansCD5 Antigens

Identifiers

PMID28514677
PMCPMC5503209
OpenAlexW2616529400

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.